Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 7

1.

Kinin-B2 receptor mediated neuroprotection after NMDA excitotoxicity is reversed in the presence of kinin-B1 receptor agonists.

Martins AH, Alves JM, Perez D, Carrasco M, Torres-Rivera W, Eterović VA, Ferchmin PA, Ulrich H.

PLoS One. 2012;7(2):e30755. doi: 10.1371/journal.pone.0030755. Epub 2012 Feb 10.

2.

[Bradykinin antagonist: current status and perspective].

Hirayama Y, Kayakiri H.

Nihon Yakurigaku Zasshi. 2002 Jan;119(1):45-53. Review. Japanese.

PMID:
11862756
3.

Bradykinin receptors and their antagonists.

Regoli D, Nsa Allogho S, Rizzi A, Gobeil FJ.

Eur J Pharmacol. 1998 May 1;348(1):1-10. Review.

PMID:
9650825
4.

Kinin B(1) receptors and the cardiovascular system: regulation of expression and function.

McLean PG, Perretti M, Ahluwalia A.

Cardiovasc Res. 2000 Nov;48(2):194-210. Review.

PMID:
11054467
5.

Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors.

Kuhr F, Lowry J, Zhang Y, Brovkovych V, Skidgel RA.

Neuropeptides. 2010 Apr;44(2):145-54. doi: 10.1016/j.npep.2009.12.004. Epub 2010 Jan 4. Review.

6.

Carboxypeptidase M augments kinin B1 receptor signaling by conformational crosstalk and enhances endothelial nitric oxide output.

Zhang X, Tan F, Brovkovych V, Zhang Y, Lowry JL, Skidgel RA.

Biol Chem. 2013 Mar;394(3):335-45. doi: 10.1515/hsz-2012-0290. Review.

7.

Kinin B1 receptors: key G-protein-coupled receptors and their role in inflammatory and painful processes.

Calixto JB, Medeiros R, Fernandes ES, Ferreira J, Cabrini DA, Campos MM.

Br J Pharmacol. 2004 Dec;143(7):803-18. Epub 2004 Nov 1. Review.

Supplemental Content

Support Center